New England Research & Management’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-24,670
Closed -$2.14M 184
2017
Q2
$2.14M Sell
24,670
-1,850
-7% -$138K 1.59% 8
2017
Q1
$1.67M Buy
26,520
+18,795
+243% +$1.24M 1.29% 16
2016
Q4
$508K Buy
7,725
+3,125
+68% +$196K 0.4% 88
2016
Q3
$319K Sell
4,600
-16,311
-78% -$1.1M 0.27% 118
2016
Q2
$1.31M Buy
20,911
+3,725
+22% +$231K 1.13% 21
2016
Q1
$1.08M Buy
17,186
+10,161
+145% +$626K 0.92% 32
2015
Q4
$479K Sell
7,025
-350
-5% -$22.8K 0.41% 84
2015
Q3
$457K Sell
7,375
-700
-9% -$47.1K 0.43% 85
2015
Q2
$519K Buy
8,075
+1,100
+16% +$74.1K 0.43% 92
2015
Q1
$481K Sell
6,975
-17,250
-71% -$1.1M 0.41% 93
2014
Q4
$1.35M Buy
24,225
+19,350
+397% +$1.12M 1.15% 11
2014
Q3
$308K Sell
4,875
-100
-2% -$5.7K 0.27% 132
2014
Q2
$263K Buy
4,975
+1,225
+33% +$61.4K 0.24% 137
2014
Q1
$203K Sell
3,750
-1,950
-34% -$99.9K 0.19% 137
2013
Q4
$258K Buy
+5,700
New +$261K 0.25% 131

Other funds holding PRXL

New England Research & Management's PRXL Position: Q3 2017 in Review

New England Research & Management sold out of Parexel International Corp (PRXL) in Q3 2017, closing a stake of 24,670 shares — an estimated $2.14M sold.

New England Research & Management first reported a position in PRXL in Q4 2013 and held it in 15 quarters. The position peaked at $2.14M in Q2 2017. 246 funds tracked by Wall St. Rank hold PRXL as of Q3 2017.

  • New England Research & Management reported no remaining Parexel International Corp position as of Q3 2017 after selling out during the quarter.
  • New England Research & Management sold 24,670 Parexel International Corp shares in Q3 2017, an estimated $2.14M.
  • New England Research & Management first reported a position in Parexel International Corp in Q4 2013 and held it in 15 quarters.
  • New England Research & Management's Parexel International Corp position peaked at $2.14M in Q2 2017.
  • 246 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2017.

Based on New England Research & Management's 13F filing for Q3 2017, filed 25 Oct 2017.